Comparison of the Immunogenicity and Safety of Three Consistency Lots of V260 in Healthy Infants

Trial Profile

Comparison of the Immunogenicity and Safety of Three Consistency Lots of V260 in Healthy Infants

Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 08 Nov 2005

At a glance

  • Drugs Rotavirus W179-9 vaccine (Primary)
  • Indications Rotavirus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 08 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top